VEMIX | WAEMX | VEMIX / WAEMX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 24 years | 17 years | - |
Gain YTD | 10.547 | -1.320 | -799% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 5000000 | 2000 | 250,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 113B | 320M | 35,313% |
Annual Yield % from dividends | 3.46 | 0.00 | - |
Returns for 1 year | 14.75 | 10.74 | 137% |
Returns for 3 years | -7.28 | -35.60 | 20% |
Returns for 5 years | 17.06 | 4.71 | 362% |
Returns for 10 years | 27.45 | 10.92 | 251% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MSDUX | 13.25 | -0.07 | -0.53% |
Morgan Stanley Emerging Mkt ex China I | |||
FEVAX | 22.58 | -0.14 | -0.62% |
First Eagle US Value A | |||
ALGAX | 19.55 | -0.24 | -1.21% |
Alger International Opportunities A | |||
HRCCX | 30.41 | -0.64 | -2.06% |
Carillon ClariVest Capital Apprec C | |||
JFNNX | 74.15 | -2.12 | -2.78% |
Janus Henderson Global Life Sciences N |